← FDA Drug Approvals (Drugs@FDA)

ADLYXIN

BLA · Biologics License Application · Sponsor: SANOFI-AVENTIS US · Approved 2016-07-27

Drug application

FDA Application #

BLA208471

Application type

Biologics License Application

Brand name

ADLYXIN

Generic name

Lixisenatide

Active ingredients

LIXISENATIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

SANOFI-AVENTIS US

First approval

2016-07-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown